Zoetis management check

ZTS · Health Care · Pharmaceuticals · CEO Kristin C. Peck

Filings as of

68
Management score, ranked 195th of 487 · 22nd of 60 in Health Care5 good · 0 to watch · 1 flaggedStrongest: clean books · Weakest: owner returns · Best and worst run in Health Care →

The seven checks

  • Flag

    Have owners done well?

    Trailed its chosen peersOwners$80Peers$188

    What $100 became since fiscal 2021

    016th
    Detail

    $100 invested at the start of fiscal 2021 grew to $80, against $188 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    9378th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.87 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Good

    What does the CEO cost owners?

    0.7% of net income

    $19.0m pay · $2.7bn net income, FY2025

    0.1%1%3%10%
    6262nd
    Detail

    $19.0m of reported pay in fiscal 2025, against $2.7bn of net income.

  • n/a

    Do they own the stock?

    No recent CEO filing
    ——

    No open-market insider buying or selling in the last six months.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 477m2025 · 444m

    Diluted shares −2.0% a year; flagged above +2%

    0%10%20%

    Stock pay 0.9% of revenue

    7567th
    Detail

    Diluted shares changed -2.0% a year over the last three fiscal years. Stock-based pay was 0.9% of revenue in the latest year.

  • Good

    Is leadership stable?

    9 leadership filings in 3 years

    9 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Kristin C. Peck

    8056th
    Detail

    CEO in the pay table: Kristin C. Peck. 9 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed April 8, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
−$15.7m$8.9m$33.5m$10020212022202320242025$80$188

Pay tied most to Revenue

Other key measuresRelative Total Shareholder ReturnAdjusted Diluted EPSFree Cash Flow

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Kristin C. Peck$19.0m$2.8m$4.0m$80$188$2.7bn
2024—$17.2m$760k$3.4m$102$148$2.5bn
2023—$15.2m$26.4m$3.0m$122$137$2.3bn
2022—$14.0m−$15.7m$2.9m$90$136$2.1bn
2021—$13.1m$33.5m$4.5m$148$126$2.0bn

Insiders and the CEO's stakeQuiet

No open-market insider buying or selling in the last six months.

Open-market trades by officers and directors since May 21, 2026.

Leadership and governance on file

20222023202420252026Leadership 13Votes 5
All 13 filings

Latest shareholder vote results: May 22, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $8.5bn returned to owners in buybacks and dividends, 73% of net income, and $337.0m of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$1.6bn$3.2bn20212022202320242025Shares477m470m462m455m444m
Show the figures
Fiscal year20212022202320242025
Revenue$7.8bn$8.1bn$8.5bn$9.3bn$9.5bn
Net income$2.0bn$2.1bn$2.3bn$2.5bn$2.7bn
Stock-based pay$58.0m$62.0m$60.0m$74.0m$83.0m
Buybacks$743.0m$1.6bn$1.1bn$1.9bn$3.2bn
Dividends—————
Diluted shares477m470m462m455m444m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.